Stryker Corp
SYK
275.40
-2.80
-1.01%
Stryker Corp
US · SYK
#199 by market cap
Listed 1970
275.40
-2.80
-1.01%
Live - 5344 symbols - heartbeat 10s ago
· 2026-10-08 08:27
Pre-market
275.57
+0.06%
After-hours
276.30
+0.33%
Overnight
275.65
+0.09%
- Market cap
- 105.64B
- P/E (TTM)i
- 28.54
- P/Bi
- 4.40
- EPSi
- 8.40
- Div yieldi
- 1.26%
- 52W posi
- 8%
Reader sentiment
Are you bullish or bearish on SYK?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 11 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.5 percentage points.
Institutional ownership
- Held by institutions
- 82.07% -0.51pp
- Institutions
- 2,667 -11
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund68.38%
Individual/Insider9.14%
Public Company4.93%
Private Company2.80%
Government Pension Fund1.68%
Sovereign Wealth Fund1.33%
Hedge Fund1.21%
Family Office/Trust0.76%
Corporate Pension Plan0.34%
Other9.43%
Top holders as of 2026-06-30
BlackRock
7.15% · 27.41M sh
Vanguard Capital Management, LLC
6.38% · 24.47M sh
John Brown
5.23% · 20.06M sh
State Street Global Advisors
4.05% · 15.53M sh
Greenleaf Trust National Association
3.97% · 15.23M sh
Other
73.22%
Ronda Stryker
3.77% · 14.47M sh
J.P. Morgan Asset Management, Inc.
3.28% · 12.59M sh
T. Rowe Price Group, Inc.
3.11% · 11.93M sh
Vanguard Portfolio Management, LLC
2.13% · 8.17M sh
Wellington Management Group
2.13% · 8.17M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 14 buys · 30 sells
| Name | Role | Stake |
|---|---|---|
| John Brown | Former Chairperson | 5.23% |
| Ronda Stryker | Independent Director | 3.77% |
| Kevin Lobo | Chairperson & CEO | 0.06% |
| J. Pierce | Group President of MedSurg & Neurotechnology | 0.02% |
| Spencer Stiles | Group President of Orthopaedics & Spine | 0.02% |
| Yin Becker | VP of Communications, Public Affairs & Corporate Marketing and Chief Corporate Affairs Officer | 0.01% |
| Viju Menon | Group President of Global Quality & Operations | 0.00% |
| Allan Golston | Independent Director | 0.00% |
| Dylan Crotty | President of Instruments | 0.00% |
| Glenn Boehnlein | VP & CFO | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-23 | Preston Wells | VP & Group CFO of Orthopaedics and Spine | Other Disposition | -109 | -- |
| 2026-09-21 | Preston Wells | VP & Group CFO of Orthopaedics and Spine | Other Disposition | -2,738 | -- |
| 2026-08-31 | Emily Baculik | Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-08-20 | Dylan Crotty | President of Instruments | Open Market Disposition | -441 | $328.61 |
| 2026-08-18 | Ronda Stryker | Independent Director | Open Market Disposition | -350,000 | $331.74–343.47 |
| 2026-08-17 | Ronda Stryker | Independent Director | Intent to Sell (Form 144) | -350,000 | $335.00 |
| 2026-08-17 | Debra King | VP, Chief Digital & Information Officer | Open Market Disposition | -826 | $336.30 |
| 2026-07-31 | M. Fink | VP & Chief Human Resources Officer | Sale to Issuer | -111 | $325.70 |
| 2026-07-31 | Robert Fletcher | VP & Chief Legal Officer | Sale to Issuer | -94 | $325.70 |
| 2026-07-31 | Debra King | VP, Chief Digital & Information Officer | Sale to Issuer | -533 | $325.70 |
| 2026-07-31 | Kimberly Montagnino | -- | Sale to Issuer | -155 | $325.70 |
| 2026-05-31 | Spencer Stiles | Group President of Orthopaedics & Spine | Other Disposition | -1,607 | -- |
| 2026-05-27 | Robert Fletcher | VP & Chief Legal Officer | Automatic Disposition | -4,544 | $304.23–310.22 |
| 2026-05-25 | Ronda Stryker | Independent Director | Open Market Disposition | -310,000 | $310.77–315.11 |
| 2026-05-10 | M. Fink | VP & Chief Human Resources Officer | Derivative Exercise and Sale | -21,582 | $154.14–294.23 |
| 2026-05-10 | M. Fink | VP & Chief Human Resources Officer | Open Market Disposition | -3,500 | $283.45 |
| 2026-05-05 | Lisa Skeete Tatum | Independent Director | Other Acquisition | +762 | -- |
| 2026-05-05 | Ronda Stryker | Independent Director | Other Acquisition | +762 | -- |
| 2026-05-05 | Mary Brainerd | Independent Director | Other Acquisition | +762 | -- |
| 2026-05-05 | Sherilyn S. McCoy | Lead Independent Director | Other Acquisition | +762 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:27:05 · For reference only, not investment advice and not tailored to your situation.